3
Letter to the Editor Response to: Comment on (Establishing a Porcine Model of Small for Size Syndrome following Liver Resection) Mohammad Golriz , Elias Khajeh , Omid Ghamarnejad , and Arianeb Mehrabi Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany Correspondence should be addressed to Arianeb Mehrabi; [email protected] Received 7 May 2018; Accepted 23 May 2018; Published 19 August 2018 Academic Editor: Pierluigi Toniutto Copyright © 2018 Mohammad Golriz et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. With great interest we read the most recent letter of Athana- siou et al. [1], this time about our publication [2]. e mentioned issues can be categorized in the following subjects: Transhepatic Flow (THF) Variations and Small for Size and Flow Syndrome (SFSF). e important role of THF variations in SFSF has been clarified by our group previously [3]. However, the mechanism and definition of SFSF should not be confused with one another. Variations in THF cause SFSF and can be considered a prerequisite factor for SFSF [4], but THF variations are not necessary for confirmation of the diagnosis. Moreover, we have previously showed the THF variations following extended liver resection [5, 6]. SFSF is diagnosed based on the clinical, laboratory, and, if possible, histopathological findings [7]. Hemodynamic variations dur- ing and aſter liver resection are measured to correlate these values with the diagnosis and to define prognostic cut-off values. Measuring hemodynamic variations could add extra information to our study but was not necessary to confirm the diagnosis. Remnant Liver Volume (RLV) and SFSF. SFSF and posthepa- tectomy liver failure (PHLF) are oſten mistaken as the same, and this is shown in the comments made by Athanasiou. is mistake is common because SFSF and PHLF are usually overlapping [8]. However, SFSF is a clinical syndrome aſter liver resection which can lead to irreversible PHLF but can also be prevented from ending in that. SFSF causes PHLF because of small RLV and increased portal vein flow per 100 gr remnant liver. An optimal animal model of SFSF for evaluating the preventive, diagnostic, and therapeutic procedures has to mirror the deterioration in liver function and have the capacity to be compensated or reversed. In the clinical setting, no surgeon will resect that much liver to make PHLF and death inevitable [9, 10]. In other words, an SFSF model should be reversible and may be rescued by intervention. However, most of the animals in SFSF model die from PHLF if no intervention is received. is can be reached in porcine model through a trisectionectomy [11– 15]. Moreover, the resection cut-off level depends on the size of segments 1, 6, and 7. If these segments are large, it is sometimes necessary to resect a further 5% to achieve the cut- off level [16, 17]. Resection that causes early death without the possibility for potential compensation (irreversible) is not an optimal SFSF model. To establish and understand a proper animal model, enough experience with the anatomy and physiology of the animal is required, especially in the respective field [18–24]. Triggers of Liver Regeneration. Triggers of liver regeneration have to be differentiated from liver regeneration itself. It is true that hypoxia may trigger liver regeneration [25]. However, constant hypoxia causes liver failure. Hypertrophy aſter liver resection is not explained by hypoxia; it is triggered by hypoxia. Moreover, the arterial buffer response cannot be reversed [26, 27]. Summary. SFSF following extended liver resection is a com- plex process that is oſten mistaken with liver failure aſter partial liver transplantation or considered as equal to PHLF. Hindawi Canadian Journal of Gastroenterology and Hepatology Volume 2018, Article ID 7565408, 2 pages https://doi.org/10.1155/2018/7565408

Response to: Comment on Establishing a Porcine Model of Small … · 2019. 7. 30. · LettertotheEditor Response to: Comment on (Establishing a Porcine Model of Small for Size Syndrome

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Letter to the EditorResponse to: Comment on (Establishing a Porcine Model ofSmall for Size Syndrome following Liver Resection)

    Mohammad Golriz , Elias Khajeh , Omid Ghamarnejad , and ArianebMehrabi

    Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

    Correspondence should be addressed to Arianeb Mehrabi; [email protected]

    Received 7 May 2018; Accepted 23 May 2018; Published 19 August 2018

    Academic Editor: Pierluigi Toniutto

    Copyright © 2018 Mohammad Golriz et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

    With great interest we read the most recent letter of Athana-siou et al. [1], this time about our publication [2]. Thementioned issues can be categorized in the following subjects:

    Transhepatic Flow (THF) Variations and Small for Size andFlow Syndrome (SFSF). The important role of THF variationsin SFSF has been clarified by our group previously [3].However, the mechanism and definition of SFSF should notbe confused with one another. Variations in THF cause SFSFand can be considered a prerequisite factor for SFSF [4], butTHF variations are not necessary for confirmation of thediagnosis. Moreover, we have previously showed the THFvariations following extended liver resection [5, 6]. SFSF isdiagnosed based on the clinical, laboratory, and, if possible,histopathological findings [7]. Hemodynamic variations dur-ing and after liver resection are measured to correlate thesevalues with the diagnosis and to define prognostic cut-offvalues. Measuring hemodynamic variations could add extrainformation to our study but was not necessary to confirmthe diagnosis.

    Remnant Liver Volume (RLV) and SFSF. SFSF and posthepa-tectomy liver failure (PHLF) are often mistaken as the same,and this is shown in the comments made by Athanasiou.This mistake is common because SFSF and PHLF are usuallyoverlapping [8]. However, SFSF is a clinical syndrome afterliver resection which can lead to irreversible PHLF but canalso be prevented from ending in that. SFSF causes PHLFbecause of small RLV and increased portal vein flow per100 gr remnant liver. An optimal animal model of SFSF

    for evaluating the preventive, diagnostic, and therapeuticprocedures has to mirror the deterioration in liver functionand have the capacity to be compensated or reversed. Inthe clinical setting, no surgeon will resect that much liverto make PHLF and death inevitable [9, 10]. In other words,an SFSF model should be reversible and may be rescued byintervention. However, most of the animals in SFSF modeldie from PHLF if no intervention is received. This can bereached in porcine model through a trisectionectomy [11–15]. Moreover, the resection cut-off level depends on the sizeof segments 1, 6, and 7. If these segments are large, it issometimes necessary to resect a further 5% to achieve the cut-off level [16, 17]. Resection that causes early death withoutthe possibility for potential compensation (irreversible) isnot an optimal SFSF model. To establish and understand aproper animal model, enough experience with the anatomyand physiology of the animal is required, especially in therespective field [18–24].

    Triggers of Liver Regeneration. Triggers of liver regenerationhave to be differentiated from liver regeneration itself. Itis true that hypoxia may trigger liver regeneration [25].However, constant hypoxia causes liver failure. Hypertrophyafter liver resection is not explained by hypoxia; it is triggeredby hypoxia. Moreover, the arterial buffer response cannot bereversed [26, 27].

    Summary. SFSF following extended liver resection is a com-plex process that is often mistaken with liver failure afterpartial liver transplantation or considered as equal to PHLF.

    HindawiCanadian Journal of Gastroenterology and HepatologyVolume 2018, Article ID 7565408, 2 pageshttps://doi.org/10.1155/2018/7565408

    http://orcid.org/0000-0002-7134-5079http://orcid.org/0000-0001-8599-0522http://orcid.org/0000-0001-7424-1323http://orcid.org/0000-0001-6163-1525https://doi.org/10.1155/2018/7565408

  • 2 Canadian Journal of Gastroenterology and Hepatology

    However, SFSF is a clinical syndrome after liver resectionwhich can lead to irreversible PHLFbut can also be preventedfrom ending in that. In other word, every SFSF is a reversiblePHLF which can end in irreversible PHLF.

    Conflicts of Interest

    The authors declare that they have no conflicts of interest.

    References

    [1] A. Athanasiou, E. Spartalis, M. Hennessy, M. Spartalis, andE. Pikoulis, “Comment on “establishing a porcine model ofsmall for size syndrome following liver resection”,” CanadianJournal of Gastroenterology andHepatology, vol. 2018, Article ID4915817, 2 pages, 2018.

    [2] M. Golriz, M. Ashrafi, E. Khajeh, A. Majlesara, C. Flechten-macher, and A. Mehrabi, “Establishing a porcine model ofsmall for size syndrome following liver resection,” CanadianJournal of Gastroenterology and Hepatology, vol. 2017, Article ID5127178, 8 pages, 2017.

    [3] M. Golriz, A. Majlesara, S. El Sakka et al., “Small for Size andFlow (SFSF) syndrome: An alternative description for posthep-atectomy liver failure,” Clinics and Research in Hepatology andGastroenterology, vol. 40, no. 3, pp. 267–275, 2015.

    [4] J. M. Asencio, J. Vaquero, L. Olmedilla, and J. L. Garcı́a Sabrido,““Small-for-flow” syndrome: Shifting the “size” paradigm,”Medical Hypotheses, vol. 80, no. 5, pp. 573–577, 2013.

    [5] M. Golriz, S. El Sakka, A. Majlesara et al., “Hepatic Hemody-namic Changes Following Stepwise Liver Resection,” Journal ofGastrointestinal Surgery, vol. 20, no. 3, pp. 1–8, 2015.

    [6] M. Golriz, A. Majlesara, E. Khajeh, and A. Mehrabi, “Reply:Hepatic Hemodynamic Changes Following Stepwise LiverResection (Golriz et al. J Gastrointest Surg (2016) 20: 587-594),”Journal of Gastrointestinal Surgery, vol. 20, no. 12, pp. 2109-2110,2016.

    [7] A. J. Demetris, D.M. Kelly, B. Eghtesad et al., “Pathophysiologicobservations and histopathologic recognition of the portalhyperperfusion or small-for-size syndrome,” The AmericanJournal of Surgical Pathology, vol. 30, no. 8, pp. 986–993, 2006.

    [8] K. Lafaro, S. Buettner, H. Maqsood et al., “Defining posthepatectomy liver insufficiency: where do we stand?” Journal ofGastrointestinal Surgery, vol. 19, no. 11, pp. 2079–2092, 2015.

    [9] A. Guglielmi, A. Ruzzenente, S. Conci, A. Valdegamberi, andC. Iacono, “How much remnant is enough in liver resection?”Digestive Surgery, vol. 29, no. 1, pp. 6–17, 2012.

    [10] C. Yigitler, O. Farges, R. Kianmanesh, J.-M. Regimbeau, E.K. Abdalla, and J. Belghiti, “The small remnant liver aftermajor liver resection: How common and how relevant?” LiverTransplantation, vol. 9, no. 9, pp. S18–S25, 2003.

    [11] R. Ladurner, B. Hochleitner, S. Schneeberger et al., “Extendedliver resection and hepatic ischemia in pigs: A new, potentiallyreversiblemodel to induce acute liver failure and study artificialliver support systems,” European Surgical Research, vol. 37, no. 6,pp. 365–369, 2005.

    [12] F. G. Court, P. E. Laws, C. P. Morrison et al., “Subtotal hepa-tectomy: A porcine model for the study of liver regeneration,”Journal of Surgical Research, vol. 116, no. 1, pp. 181–186, 2004.

    [13] T. Iida, S. Yagi, K. Taniguchi, T. Hori, and S. Uemoto, “Improve-ment of Morphological Changes after 70% Hepatectomy with

    Portocaval Shunt: Preclinical Study in Porcine Model,” Journalof Surgical Research, vol. 143, no. 2, pp. 238–246, 2007.

    [14] H. Wege, A. Müller, L. Müller, S. Petri, J. Petersen, and C.Hillert, “Regeneration in pig livers by compensatory hyper-plasia induces high levels of telomerase activity,” ComparativeHepatology, vol. 6, no. 1, p. 6, 2007.

    [15] R. Ladurner, M. Schenk, R. Margreiter, F. Offner, and A.Königsrainer, “Influence of portosystemic shunt on liver regen-eration after hepatic resection in pigs,” HPB Surgery, vol. 2009,p. 835965, 2009.

    [16] S. M. Niehues, J. K. Unger, M. Malinowski, J. Neymeyer,B. Hamm, and M. Stockmann, “Liver volume measurement:reason of the difference between in vivo CT-volumetry andintraoperative ex vivo determination and how to cope it,”European Journal of Medical Research, vol. 15, no. 8, pp. 345–350, 2010.

    [17] F. G. Court, S. A. Wemyss-Holden, C. P. Morrison et al.,“Segmental nature of the porcine liver and its potential as amodel for experimental partial hepatectomy,” British Journal ofSurgery, vol. 90, no. 4, pp. 440–444, 2003.

    [18] M. Golriz, S. Abbasi, P. Fathi, A. Majlesara, T. Brenner, and A.Mehrabi, “Does acid-base equilibrium correlate with remnantliver volume during stepwise liver resection?”American Journalof Physiology-Gastrointestinal and Liver Physiology, vol. 313, pp.G313–g319, 2017.

    [19] A. Groth, S. Ottinger, C. Kleist et al., “Evaluation of porcinemesenchymal stem cells for therapeutic use in human livercancer,” International Journal of Oncology, vol. 40, no. 2, pp. 391–401, 2012.

    [20] G. Millonig, S. Friedrich, S. Adolf et al., “Liver stiffness isdirectly influenced by central venous pressure,” Journal ofHepatology, vol. 52, no. 2, pp. 206–210, 2010.

    [21] M. Soleimani, H. Fonouni,M. Esmaeilzadeh et al., “Appropriatedonor size for porcine liver xenotransplant,” Experimental andClinical Transplantation, vol. 10, no. 2, pp. 148–153, 2012.

    [22] M. Esmaeilzadeh, A.Nickkholgh, A.Majlesara et al., “Technicalguidelines for porcine liver allo-transplantation: A review ofliterature,” Annals of Transplantation, vol. 17, no. 2, pp. 101–110,2012.

    [23] T. Gehrig, G. Manzini, H. Fonouni et al., “Comparison oftwo different transection techniques in liver surgery - Anexperimental study in a porcine model,” Langenbeck’s Archivesof Surgery, vol. 398, no. 6, pp. 909–915, 2013.

    [24] M. Golriz, M. Hafezi, C. Garoussi et al., “Do we need animalhands-on courses for transplantation surgery?” Clinical Trans-plantation, vol. 27, supplement 25, pp. 6–15, 2013.

    [25] E. Schadde, C. Tsatsaris, M. Swiderska-Syn et al., “Hypoxia ofthe growing liver accelerates regeneration,” Surgery, vol. 161, no.3, pp. 666–679, 2017.

    [26] H. Ho, K. Sorrell, A. Bartlett, and P. Hunter, “Modeling thehepatic arterial buffer response in the liver,”Medical Engineering& Physics, vol. 35, no. 8, pp. 1053–1058, 2013.

    [27] C. Eipel, K. Abshagen, and B. Vollmar, “Regulation of hepaticblood flow: the hepatic arterial buffer response revisited,”WorldJournal of Gastroenterology, vol. 16, no. 48, pp. 6046–6057, 2010.

  • Stem Cells International

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    MEDIATORSINFLAMMATION

    of

    EndocrinologyInternational Journal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Disease Markers

    Hindawiwww.hindawi.com Volume 2018

    BioMed Research International

    OncologyJournal of

    Hindawiwww.hindawi.com Volume 2013

    Hindawiwww.hindawi.com Volume 2018

    Oxidative Medicine and Cellular Longevity

    Hindawiwww.hindawi.com Volume 2018

    PPAR Research

    Hindawi Publishing Corporation http://www.hindawi.com Volume 2013Hindawiwww.hindawi.com

    The Scientific World Journal

    Volume 2018

    Immunology ResearchHindawiwww.hindawi.com Volume 2018

    Journal of

    ObesityJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Computational and Mathematical Methods in Medicine

    Hindawiwww.hindawi.com Volume 2018

    Behavioural Neurology

    OphthalmologyJournal of

    Hindawiwww.hindawi.com Volume 2018

    Diabetes ResearchJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Research and TreatmentAIDS

    Hindawiwww.hindawi.com Volume 2018

    Gastroenterology Research and Practice

    Hindawiwww.hindawi.com Volume 2018

    Parkinson’s Disease

    Evidence-Based Complementary andAlternative Medicine

    Volume 2018Hindawiwww.hindawi.com

    Submit your manuscripts atwww.hindawi.com

    https://www.hindawi.com/journals/sci/https://www.hindawi.com/journals/mi/https://www.hindawi.com/journals/ije/https://www.hindawi.com/journals/dm/https://www.hindawi.com/journals/bmri/https://www.hindawi.com/journals/jo/https://www.hindawi.com/journals/omcl/https://www.hindawi.com/journals/ppar/https://www.hindawi.com/journals/tswj/https://www.hindawi.com/journals/jir/https://www.hindawi.com/journals/jobe/https://www.hindawi.com/journals/cmmm/https://www.hindawi.com/journals/bn/https://www.hindawi.com/journals/joph/https://www.hindawi.com/journals/jdr/https://www.hindawi.com/journals/art/https://www.hindawi.com/journals/grp/https://www.hindawi.com/journals/pd/https://www.hindawi.com/journals/ecam/https://www.hindawi.com/https://www.hindawi.com/